Hexima recently took the opportunity to speak with certain of its Scientific Advisory Board members about Onychomycosis: the disease, its treatment and the potential for a new therapy like pezadeftide. We captured videos of these interactions which you can view below.
Use the below grid to view the full interviews or jump straight to answers for questions of interest.
Dr Robert Rosen
Dr Tracey C. Vlahovic
Dr Warren Joseph
Q. What is onychomycosis, how does it occur and do genetics play a role in the likelihood of developing this infection?
Q. How infectious is onychomycosis? Does it spread to other parts of the body, from person to person?
Q. Do you think a product that improves the appearance of the nail faster would lead to increased compliance and reduce therapy abandonment?